Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,515.95
+32.50 (2.19%)
At close: Feb 6, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 287.34 billion as of February 6, 2026. Its market cap has increased by 9.25% in one year.
Market Cap
287.34B
Enterprise Value
300.22B
Revenue
88.50B
Ranking
n/a
PE Ratio
33.03
Stock Price
1,515.95
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 287.34B, an increase of 11.83%. That is a compound annual growth rate of 7.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 287.34B | 11.08% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 581.67B |
| GlaxoSmithKline Pharmaceuticals | 421.12B |
| J. B. Chemicals & Pharmaceuticals | 297.06B |
| AstraZeneca Pharma India | 214.54B |
| Jubilant Pharmova | 147.91B |
| Caplin Point Laboratories | 138.78B |
| Granules India | 136.94B |
| Rubicon Research | 129.27B |